FTRE241220C50000
- 2.40
- 0.000.00%
Fortrea Holdings Newsroom
A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $25 to $30
Deutsche Bank Adjusts Fortrea Price Target to $23 From $21, Maintains Hold Rating
Fortrea Holdings Is Maintained at Outperform by Baird
Baird Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $30
Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $25
TD Cowen Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Raises Target Price to $25
Fortrea Holdings Inc.: Hold Rating Amid Uncertain Revenue Growth and Cost Optimization
Barclays Remains a Hold on Fortrea Holdings Inc. (FTRE)
Fortrea Holdings Analyst Ratings
Evercore Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $20
Fortrea Holdings Inc. (FTRE) Gets a Hold From Evercore ISI
Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $20
Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $20
Fortrea Holdings Is Maintained at In-Line by Evercore ISI Group
Fortrea Holdings Analyst Ratings
Evercore Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $20
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and PDS Biotechnology (PDSB)
Fortrea Holdings Analyst Ratings
Deutsche Bank Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Cuts Target Price to $23
A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $21 to $30